Connect with us

Headlines

There’s a Problem with the Luxottica-Essilor Merger

The combined organization is plagued by infighting.

mm

Published

on

Things aren’t going so well at EssilorLuxottica SA, the company created by the merger of Essilor International and Luxottica Group, Bloomberg reports.

The organization is plagued by infighting among its leadership. Its share price is down 22 percent since the October merger, Bloomberg notes.

Luxottica founder Leonardo Del Vecchio says Essilor’s leaders aren’t sticking to the agreed-upon terms of corporate governance, according to Bloomberg. He’s the combined company’s largest shareholder and serves as its executive chairman.

Meanwhile, Essilor’s Hubert Sagnieres, who serves as vice chairman of the merged organization, says Del Vecchio has staged a “de facto attempt to take control of the new group.” He claims Del Vecchio has made false accusations as to the group’s governance and management.

Del Vecchio previously told Le Figaro, a French newspaper, that Sagnieres failed to communicate with him on matters such as filling key management jobs.

“He has acted as if Essilor bought Luxottica,” Del Vecchio was quoted saying.

Advertisement

The companies completed their merger in October.

Following the contribution by Delfin, at the time the majority shareholder of Luxottica, of its 62.42 percent stake in Luxottica to Essilor on Oct. 1, Essilor became the parent company of Luxottica and was renamed EssilorLuxottica.

Read more at Bloomberg

Since launching in 2014, INVISION has won 21 international journalism awards for its publication and website. Contact INVISION's editors at editor@invisionmag.com.

Advertisement

SPONSORED VIDEO

SPONSORED BY WALMAN OPTICAL

People Want to Buy Premium Products

Walman Optical Presents—Industry Myths Busted! It’s up to every ECP to explain that “premium” doesn’t mean expensive—it means “customized to your needs.”

Promoted Headlines

Headlines

Pharma Company with Eyecare Focus Names CEO

He previously served as interim chief.

mm

Published

on

EMERYVILLE, CA — NovaBay Pharmaceuticals Inc., a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, announces the appointments of Justin Hall as president and CEO and Jason Raleigh as chief financial officer.

Hall has served as interim president and CEO, and Raleigh as interim CFO, since March 2019.

“Justin and Jason have proven their leadership abilities by successfully implementing the shift in our U.S. commercial strategy we announced in March and executing the recent launch of our U.S. direct-to-consumer sales of Avenova on Amazon.com,” said Paul E. Freiman, chairman of NovaBay.

“This is a very exciting time at NovaBay as we launch Avenova Direct, making our leading lid and lash spray directly accessible to consumers without a prescription and at affordable pricing,” Hall said. “My close working relationships with our Board, principal investors, and sales force are key to quickly adjusting our strategy to rapidly address opportunities in the marketplace. We are on the move and we have momentum.”

Advertisement

Raleigh said: “I’m honored to be selected as CFO and appreciate the Board’s trust in my abilities. I look forward to continuing to work with Justin and the NovaBay team toward the continued successful commercialization of Avenova.”

Hall has served with NovaBay for six years in a variety of roles, including as corporate counsel, and has been actively involved in a number of operating functions, including the sales organization and manufacturing. Raleigh has been with NovaBay for more than three years and has nearly 20 years of financial experience.

Continue Reading

Headlines

AOA: Amazon Has Dropped Noncompliant Contact Lens Sellers

AOA plans to ‘continue to monitor the site and report retailers.’

mm

Published

on

The American Optometric Association reports that Amazon’s marketplace no longer displays noncompliant, decorative contact lens vendors following complaints from the AOA.

The AOA explains that it had alerted the e-commerce retailer to potential violations of federal law and its own medical device policy.

In a Feb. 27 letter to Amazon, the AOA emphasized that contact lenses — whether corrective or plano — are U.S. Food and Drug Administration-regulated medical devices that not only require a prescription from a licensed practitioner for purchase, but also fall under Amazon’s own policy for “Medical Devices and Accessories.” That policy mandates how sellers must abide by all federal, state and local laws, which in this case, the AOA noted, includes patient protection provisions of the Fairness to Contact Lens Consumer Act (FCLCA).

Per federal law, vendors “may sell contact lenses only in accordance with a contact lens prescription for the patient that is (1) presented to the seller by the patient or prescriber directly or by facsimile; or (2) verified by direct communication.”

AOA’s letter noted: “The contact lenses available for sale on Amazon are sold entirely without a prescription, which we believe is an FCLCA violation.” Furthermore, “in addition to sales via (Amazon’s) platform raising legal questions related to the FCLCA, the guidance provided by sellers regarding these FDA-regulated medical devices is very concerning.”

The AOA’s letter document instructions from vendors such as “… gently press the contact lens opposite clockwise or counterclockwise turn 30 times [sic], and put in a box for a new care solution … if you do not use for a long time, please put in the box, soak with care solution [sic], replace the care solution every three days.”

Such guidance is “wholly inappropriate and dangerous,” the AOA states in a post on its website. It notes that proper physician oversight is necessary for medical devices that require a physician’s prescription.

According to AOA:

In response, Amazon thanked AOA for its diligence and reiterated its own medical devices policy while stating the company will take appropriate action when products are reported for legal non-compliance. As of June 4, those violating posts that AOA first identified and reported have been removed. The AOA will continue to monitor the site and report retailers.

Continue Reading

Headlines

Ophthalmologists Hope to Undo State Law That Allows ODs to Perform Eye Surgery

They’re attempting a ballot referendum.

mm

Published

on

A movement is afoot in Arkansas to undo recently passed state legislation that allows optometrists to perform certain surgeries.

It’s being led by Safe Surgery Arkansas, a group of medical doctors, Talk Business & Politics reports. They hope to use a ballot referendum to accomplish their goal.

R. Scott Lowery, president of the Arkansas Ophthalmological Society, was quoted saying: “Every day the people of Arkansas rely on medical doctors who have the experience and training to perform medical procedures to ensure that they are getting world class healthcare in Arkansas. We are confident that when the people are heard on this issue, they will not allow individuals without medical degrees and without surgical residencies to jeopardize the precious eyesight of Arkansans.”

The legislation was signed into law in March. The procedures that it allows optometrists to perform include selective laser trabeculoplasty and Nd:YAG laser procedures, along with injections (excluding intravenous and intraocular), removal of lid lesions and chalazion incision and curettage.

Advertisement

The bill called on the Arkansas Board of Optometry to establish credentialing requirements for optometrists to perform these laser procedures, as well as require those doctors to report the outcomes of their procedures to the board.

Vicki Farmer, executive director of the Arkansas Optometry Association, was quoted noting that Arkansas legislators “overwhelmingly approved this measure during the recent session, after listening to hours of testimony and debate, and learning optometrists in other states, like Oklahoma, have been safely performing these procedures for more than 20 years.”

Read more at Talk Business & Politics

Continue Reading

Advertisement

Advertisement

Advertisement

Most Popular